Alessandra Fusco, Sara Colarusso, Marco Piscopo, Maria Rosaria Improta, and Marco Corigliano, “Short-term Cardio-Vascular Risk Score Changes in Type 2 Diabetic Patients on Empaglifozin: A Real-Life Clinical Experience”, HROJ, vol. 4, no. 3, pp. 46–56, Jul. 2017.